111 related articles for article (PubMed ID: 11001389)
1. Cytotoxicity of aphidicolin and its derivatives against neuroblastoma cells in vitro: synergism with doxorubicin and vincristine.
Michaelis M; Vogel JU; Cinatl J; Langer K; Kreuter J; Schwabe D; Driever PH; Cinatl J
Anticancer Drugs; 2000 Jul; 11(6):479-85. PubMed ID: 11001389
[TBL] [Abstract][Full Text] [Related]
2. Treatment of drug-resistant human neuroblastoma cells with cyclodextrin inclusion complexes of aphidicolin.
Michaelis M; Cinatl J; Vogel JU; Pouckova P; Driever PH; Cinatl J
Anticancer Drugs; 2001 Jun; 12(5):467-73. PubMed ID: 11395575
[TBL] [Abstract][Full Text] [Related]
3. Aphidicolin glycinate inhibits human neuroblastoma cell growth in vivo.
Cinatl J; Cinatl J; Kotchetkov R; Driever PH; Bertels S; Siems K; Jas G; Bindseil K; Rabenau HF; Pouckova P; Doerr HW; Schwabe D
Oncol Rep; 1999; 6(3):563-8. PubMed ID: 10203592
[TBL] [Abstract][Full Text] [Related]
4. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
[TBL] [Abstract][Full Text] [Related]
5. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
[TBL] [Abstract][Full Text] [Related]
6. Aphidicolin selectively kills neuroblastoma cells in vitro.
Cinatl J; Cinatl J; Mainke M; Weissflog A; Steigmann G; Rabenau H; Doerr HW; Kornhuber B
Cancer Lett; 1992 Dec; 67(2-3):199-206. PubMed ID: 1483268
[TBL] [Abstract][Full Text] [Related]
7. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
8. Increased efficacy of aphidicolin killing of human neuroblastoma cells in vitro by encapsulation in liposomes.
Cinatl J; Hernáiz Driever P; Cinatl J; Rückert DG; Gümbel HO; Rabenau H; Kornhuber B; Doerr HW
Neoplasma; 1997; 44(2):91-5. PubMed ID: 9201287
[TBL] [Abstract][Full Text] [Related]
9. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
[TBL] [Abstract][Full Text] [Related]
11. Increased systemic efficacy of aphidicolin encapsulated in liposomes.
Michaelis M; Zimmer A; Handjou N; Cinatl J; Cinatl J
Oncol Rep; 2005 Jan; 13(1):157-60. PubMed ID: 15583818
[TBL] [Abstract][Full Text] [Related]
12. Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.
Cinatl J; Cinatl J; Kotchetkov R; Matousek J; Woodcock BG; Koehl U; Vogel JU; Kornhuber B; Schwabe D
Anticancer Res; 2000; 20(2A):853-9. PubMed ID: 10810366
[TBL] [Abstract][Full Text] [Related]
13. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro.
Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129
[TBL] [Abstract][Full Text] [Related]
15. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
16. Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization.
Bedrnicek J; Vicha A; Jarosova M; Holzerova M; Cinatl J; Michaelis M; Cinatl J; Eckschlager T
Neoplasma; 2005; 52(5):415-9. PubMed ID: 16151587
[TBL] [Abstract][Full Text] [Related]
17. Suppression of anti-microtubule agent-induced apoptosis by nitric oxide: possible mechanism of a new drug resistance.
Ogura T; DeGeorge G; Tatemichi M; Esumi H
Jpn J Cancer Res; 1998 Feb; 89(2):199-205. PubMed ID: 9548448
[TBL] [Abstract][Full Text] [Related]
18. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
Sietsma H; Veldman RJ; Kolk D; Ausema B; Nijhof W; Kamps W; Vellenga E; Kok JW
Clin Cancer Res; 2000 Mar; 6(3):942-8. PubMed ID: 10741719
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading.
Abraham SA; McKenzie C; Masin D; Ng R; Harasym TO; Mayer LD; Bally MB
Clin Cancer Res; 2004 Jan; 10(2):728-38. PubMed ID: 14760096
[TBL] [Abstract][Full Text] [Related]
20. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
Geng X; Xie L; Xing H
Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
